Clinical Research Directory
Browse clinical research sites, groups, and studies.
99Tc-MDP Treatment for Knee Osteoarthritis
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Summary
Osteoarthritis (OA) of knee is the most common form of arthritis in the world1e, and it has received growing attention in the society because of the increase of old age population, disabled people, and medical expenses from this disease. 99Tc-MDP is effective for rheumatoid arthritis. Therefore, the investigators try to investigate the effects of 99Tc-MDP treatment in patients with osteoarthritis of knee as compared with celecoxib.
Official title: 99Tc-MDP Versus Celecoxib Treatment in Patients With Knee Osteoarthritis
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2017-09-01
Completion Date
2025-12-30
Last Updated
2024-12-03
Healthy Volunteers
No
Conditions
Interventions
99Tc-MDP
99Tc-MDP 15mg in 100ml normal saline intravenously dripped every twice a week for 5 weeks, every 1weeks for 10 weeks, every 2weeks for 10 weeks, every 1 month for 6 months.
Celecoxib
Celecoxib capsule 200mg qd by mouth.
Locations (1)
Department of Nuclear Medicine, Tenth People's Hospital of Tongji University
Shanghai, Shanghai Municipality, China